{"entity":{"type":"insider","cik":"0001437909","url":"/insider/0001437909","json_url":"/insider/0001437909.json","name":"Lewis-Hall Freda C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2008-12-12","last":"2019-09-19","span_basis":"filed_date"},"name_variants":[{"name":"Lewis-Hall Freda C","source":"filing","n_filings":5,"first_seen":"2008-12-12","last_seen":"2019-09-19"}],"transactions":[{"id":8709912,"accession":"0001144204-19-045298","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-19-045298","line_url":"/filing/0001144204-19-045298#line-4","is_derivative":false,"issuer_cik":"0001437909","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001437909","owner_cik":"0001437909","owner_name":"Lewis-Hall Freda C","owner_display_name":"Lewis-Hall Freda C","owner_url":"/insider/0001437909","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","total_whole":"900,000","shares_owned_after":4593847.0,"shares_owned_after_display":"4,593,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-17","filed_date":"2019-09-19","scope":"insider"},{"id":4877805,"accession":"0001225208-13-020211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-13-020211","line_url":"/filing/0001225208-13-020211#line-1","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"PFIZER INC","issuer_ticker":"PFE","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":"0001437909","owner_name":"Lewis-Hall Freda C","owner_display_name":"Lewis-Hall Freda C","owner_url":"/insider/0001437909","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38461.0,"shares_display":"38,461","price_per_share":28.7,"price_display":"28.70","price_state":"stated","total_value":1103830.7,"total_display":"1,103,830.70","total_whole":"1,103,831","shares_owned_after":118383.0,"shares_owned_after_display":"118,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-09-18","scope":"insider"},{"id":5830155,"accession":"0000875320-09-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-09-000018","line_url":"/filing/0000875320-09-000018#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001437909","owner_name":"Lewis-Hall Freda C","owner_display_name":"Lewis-Hall Freda C","owner_url":"/insider/0001437909","role":"Officer (EVP, Medicines Development)","role_mark":"O","role_mark_label":"Officer (EVP, Medicines Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medicines Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":29.11,"price_display":"29.11","price_state":"stated","total_value":36387.5,"total_display":"36,387.50","total_whole":"36,388","shares_owned_after":53334.0,"shares_owned_after_display":"53,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-19","filed_date":"2009-03-20","scope":"insider"},{"id":2743129,"accession":"0000875320-08-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-08-000097","line_url":"/filing/0000875320-08-000097#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001437909","owner_name":"Lewis-Hall Freda C","owner_display_name":"Lewis-Hall Freda C","owner_url":"/insider/0001437909","role":"Officer (EVP, Medicines Development)","role_mark":"O","role_mark_label":"Officer (EVP, Medicines Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medicines Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":29.9,"price_display":"29.90","price_state":"stated","total_value":37375.0,"total_display":"37,375.00","total_whole":"37,375","shares_owned_after":42500.0,"shares_owned_after_display":"42,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-19","filed_date":"2008-12-22","scope":"insider"},{"id":3335327,"accession":"0000875320-08-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-08-000094","line_url":"/filing/0000875320-08-000094#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001437909","owner_name":"Lewis-Hall Freda C","owner_display_name":"Lewis-Hall Freda C","owner_url":"/insider/0001437909","role":"Officer (EVP, Medicines Development)","role_mark":"O","role_mark_label":"Officer (EVP, Medicines Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medicines Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1098.0,"shares_display":"1,098","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":28548.0,"total_display":"28,548.00","total_whole":"28,548","shares_owned_after":43750.0,"shares_owned_after_display":"43,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-11","filed_date":"2008-12-12","scope":"insider"},{"id":3335320,"accession":"0000875320-08-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-08-000094","line_url":"/filing/0000875320-08-000094#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001437909","owner_name":"Lewis-Hall Freda C","owner_display_name":"Lewis-Hall Freda C","owner_url":"/insider/0001437909","role":"Officer (EVP, Medicines Development)","role_mark":"O","role_mark_label":"Officer (EVP, Medicines Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medicines Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152.0,"shares_display":"152","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":3952.0,"total_display":"3,952.00","total_whole":"3,952","shares_owned_after":44848.0,"shares_owned_after_display":"44,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-10","filed_date":"2008-12-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001773427","name":"SpringWorks Therapeutics, Inc.","url":"/issuer/0001773427","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2019-09-19","last_seen":"2019-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000078003","name":"PFIZER INC","url":"/issuer/0000078003","role":"Officer (Executive Vice President)","n_filings":1,"first_seen":"2013-09-18","last_seen":"2013-09-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP, Medicines Development)","n_filings":3,"first_seen":"2008-12-12","last_seen":"2009-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001437909","retrieved_at":"2026-08-22T13:26:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}